Sage Journals: Discover world-class research

Abstract

Using non-blinded methodology, this study checked the coding of acute leukaemia, non-acute leukaemia and lymphoma episodes assigned to the AR-DRGs R60 A, B, C and R61 A, B during the fiscal year 2000–2001 at a Sydney teaching hospital. The purpose was to investigate whether the assignment of fewer episodes of these diseases to the highest complexity AR-DRGs during that year compared to 1999–2000 was due to miscoding, or due to a true decrease in episodes. A check of all 242 episodes revealed a degree of miscoding (mainly under-coding) of complications and comorbidities that had caused a 15% DRG error rate; nevertheless, there was a true decrease in the highest complexity episodes. The error in DRG assignment may have caused some financial disadvantage to the hospital.

Keywords

Coding leukaemia lymphoma AR-DRGs

Get full access to this article

View all access options for this article.

References

Beguin

Y. A.

(1998). Risk-benefit assessment of epoetin in the management of anaemia associated with cancer. Drug Safety 19(4): 269–282.

Colton

(1974). Statistics in Medicine. Boston, Little, Brown & Co.

Commonwealth Department of Health and Aged Care (1998). Australian Refined Diagnosis Related Groups, version 4.1. Definitions Manual. Vol. 1. Canberra, Commonwealth of Australia.

Donoghue

(1992). The prevalence and cost of documentation and coding errors. Australian Medical Record Journal 22(3): 91–97.

Eagar

Hindle

(1994). Casemix in Australia: An overview. Canberra, Commonwealth of Australia.

Guest

Utrecht

(2001). Bone marrow cell protection from chemotherapy by low-molecular-weight compounds. Experimental Hematology 229(2): 123–137.

Karp

J.E.

Merz

W.G.

Charache

(1991). Response to empiric amphotericin B during antileukemic therapy-induced granulocytopenia. Reviews of Infectious Diseases 13(4): 592–599.

MacIntyre

C.R.

Ackland

M.J.

Chandraraj

E.J.

Pilla

J.E.

(1997). Accuracy of ICD-9-CM codes in hospital morbidity data, Victoria: Implications for public health research. Australian and New Zealand Journal of Public Health 21: 477–482.

Moss

(2002). Funding of South Australian public hospitals. Australian Health Review 25(1): 156–172.

10.

National Centre for Classification in Health (2000). International Classification of Diseases 10th Revision, Australian Modification, 2nd edition, vol 5. Sydney, National Centre for Classification in Health.

11.

Redaelli

Botteman

M.F.

Stephens

J.M.

Brandt

Pashos

C.L.

(2004). Economic burden of acute myeloid leukaemia. Cancer Treatment Review 30(3): 237–247.

12.

Stevens

Unwin

C.E.

Codde

J.P.

(1998). A review of hospital medical record audits: Implications for funding and training. Australian Health Review 21:78–91.

13.

Zhang

Marshall

McAlister

Hirsch

(1997). The diagnosis severity indicators in Australia. Australian Casemix Bulletin 8(4): 9–11.

Investigation of Leukaemia and Lymphoma AR-DRGs at a Sydney Teaching Hospital

Abstract

Keywords

Get full access to this article

References